PWPS
MRVI icon

Pinnacle Wealth Planning Services’s Maravai LifeSciences MRVI Stock Holding History

Pinnacle Wealth Planning Services’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45.1K Hold
7,220
– – ﹤0.01% 1349
2026
Q1 		$20.4K Hold
7,220
– – ﹤0.01% 1687
2025
Q4 		$23.5K Buy
+7,220
New +$24.3K ﹤0.01% 1643
2021
Q1 		– Sell
-1,102
Closed -$31K – 1331
2020
Q4 		$31K Buy
+1,102
New +$30.7K 0.01% 987

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Pinnacle Wealth Planning Services's MRVI Position: Q2 2026 in Review

Pinnacle Wealth Planning Services held its Maravai LifeSciences (MRVI) position steady in Q2 2026 at 7,220 shares worth $45.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1349.

Pinnacle Wealth Planning Services first reported a position in MRVI in Q4 2020 and has held it in 4 quarters since. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • Pinnacle Wealth Planning Services held 7,220 shares of Maravai LifeSciences worth $45.1K as of Q2 2026.
  • Pinnacle Wealth Planning Services left its Maravai LifeSciences share count unchanged in Q2 2026.
  • Maravai LifeSciences made up ﹤0.01% of Pinnacle Wealth Planning Services's portfolio in Q2 2026, its #1349 holding.
  • Pinnacle Wealth Planning Services first reported a position in Maravai LifeSciences in Q4 2020 and has held it in 4 quarters since.
  • 178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q2 2026, filed 7 Aug 2026.